Dr. Vinay Prasad is out at the Food and Drug Administration for the second and hopefully last time within the past 12 months. The controversial drug regulator had placed multiple stumbling blocks before patients seeking care for grave and rare genetic conditions. Let us hope the FDA’s culture changes with his exit.
Read Full Article »
